All StatesCaliforniaAlameda CountyRo Khanna › Evidence
Neutral Bill Mar 16, 2026

To direct the Chairman of the Joint Chiefs of Staff to conduct a feasibility study on incorporating militarily-relevant applications of emerging biotechnology into wargaming exercises, and for other purposes.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 5193 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 5193 To direct the Chairman of the Joint Chiefs of Staff to conduct a feasibility study on incorporating militarily-relevant applications of emerging biotechnology into wargaming exercises, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES September 8, 2025 Mr. Khanna (for himself, Mr. Garamendi, and Mr. Davis of North Carolina) introduced the following bill; which was referred to the Committee on Armed Services _______________________________________________________________________ A BILL To direct the Chairman of the Joint Chiefs of Staff to conduct a feasibility study on incorporating militarily-relevant applications of emerging biotechnology into wargaming exercises, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. FEASIBILITY STUDY ON INCORPORATING MILITARILY RELEVANT APPLICATIONS OF EMERGING BIOTECHNOLOGY INTO WARGAMING EXERCISES. (a) In General.--The Chairman of the Joint Chiefs of Staff shall conduct a review to determine the feasibility and advisability modifying the design of wargaming exercises to ensure that such exercises incorporate militarily relevant applications of emerging biotechnology. (b) Elements.--In conducting the review required under subsection (a), the Chairman of the Joint Chiefs of Staff shall take into account-- (1) biotechnology-enabled enhancements that improve the cognitive and physical performance of warfighters; (2) biotechnology-enabled chemicals and materials intended to provide a strategic advantage on the battlefield; (3) adversaries' use of biotechnology for military purposes beyond traditional biological weapons; and (4) any other militarily relevant applications of biotechnology determined appropr

https://www.congress.gov/bill/119th-congress/house-bill/5193
Ro Khanna U.S. Representative
Armed Forces and National Security
Share on X Share on Facebook
← Back to Ro Khanna's profile